Philips introduces integrated Interventional Hemodynamic System with Patient Monitor IntelliVue X3 to improve workflow and pa...
May 14 2021 - 3:00AM
Philips introduces integrated Interventional Hemodynamic System
with Patient Monitor IntelliVue X3 to improve workflow and patient
focus during image-guided procedures at ACC.21
May 14, 2021
Continuous monitoring provides informed, timely clinical
decision making and comprehensive, gap-free patient records in the
cath lab and beyond
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced the integration of its Interventional Hemodynamic System
and market-leading portable Patient Monitor IntelliVue X3,
providing advanced hemodynamic (blood flow) measurements at the
tableside in the cath lab and continuous monitoring of key vital
signs throughout the patient journey [1]. The integration provides
the opportunity for monitoring during image-guided procedures on
the Philips Image Guided Therapy System – Azurion, improving
workflow with comprehensive patient records that support timely
clinical decision-making during interventional cardiology
procedures and beyond. The solution will be introduced at ACC.21,
the American College of Cardiology’s 70th Annual Scientific Session
and Expo, taking place virtually on May 15-17.
Health systems strive to deliver consistent quality patient care
while optimizing the interventional room to treat more patients and
accelerate care of the critically ill. Uninterrupted patient
monitoring, as patients are moved from holding areas to the
interventional room and then on to recovery areas, can help to
improve clinical decision making and the timely detection of
potential adverse events at every stage of the patient journey.
Incorporating a 12-lead diagnostic ECG, the monitor removes the
need to re-cable the patient or reconnect monitoring, and can help
lead to reduced procedural preparation time, enhanced staff
efficiency and ultimately an enhanced patient experience.
“Philips Interventional Hemodynamic System with Patient Monitor
IntelliVue X3 is a unique combination made possible by our
strengths in patient monitoring and image-guided therapy,” said
Ronald Tabaksblat, General Manager Image Guided Therapy Systems at
Philips. “Bringing advanced hemodynamic measurements to the
tableside as an integrated part of our Azurion image-guided therapy
system, it helps allow clinicians to assess the condition of the
patient in real time during an intervention, without leaving the
sterile field. It also streamlines workflows, providing continuous
monitoring of the patient during every step of their care path,
enhancing patient safety and confidence.”
The IntelliVue X3 patient monitor can be connected to the
patient from anywhere in the hospital, after which it stays with
them throughout the interventional procedure, providing continuous
monitoring and registration of their vital signs in the IntelliVue
IT solution.
After connecting the IntelliVue X3 to its docking station at the
tableside of the Azurion system, clinical staff can monitor all of
the patient’s vital signs including pulse oximetry end-tidal CO2,
perform hemodynamic analyses and 12-lead ECG acquisitions, and
relay results and waveforms from the lab’s control room to the
Azurion tableside display. From the tableside the
interventionalists can assess the data using the Azurion tableside
Touch Screen Module, allowing them to remain focused on their
patients. The system brings the latest physiological techniques to
the interventional lab, including iFR (instant wave-Free Ratio)
measurements, a hyperemia-free technique unique to Philips that
provides valuable functional information regarding the severity of
lesions in the coronary arteries.
Philips Interventional Hemodynamic System with Patient Monitor
IntelliVue X3 integrates with Azurion, the company’s
next-generation image-guided therapy system that allows clinicians
to easily and confidently perform procedures with a unique user
experience, helping to optimize lab performance and provide
superior care. At ACC.21 Philips will showcase its solutions for
the diagnosis and treatment of Structural Heart Disease, which aim
to remove the barriers associated with complex procedures by
helping to deliver clinical confidence where it is needed most – at
the point of treatment. Philips’ cardiac care solutions help
strengthen clinical confidence, build efficiency throughout the
care pathway, and enhance care experiences. For more information
visit www.philips.com/acc.
[1] Philips Interventional Hemodynamic System with Patient
Monitor IntelliVue X3 is available in the majority of markets
worldwide. Philips’ continuous patient monitoring solution is
available for sale in markets across Europe, Middle East and APAC,
with further expansion planned later this year. It is not available
for sale in the U.S.
For further information, please contact:
Mark GrovesPhilips Global Press OfficeTel: +31 631 639 916Email:
mark.groves@philips.com
Anna HogrebePhilips Global Press OfficeTel.: +1 416 270
6757Email: anna.hogrebe@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 17.3 billion and
employs approximately 77,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Philips Interventional Hemodynamic System with Patient Monitor
IntelliVue X3
- Philips Interventional Hemodynamic System with Patient Monitor
IntelliVue X3 patient transit
- Philips Interventional Hemodynamic System with Patient Monitor
IntelliVue X3 cath lab
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Apr 2023 to Apr 2024